Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Targeted Oncology|October 31, 2021
Phase II Study of Third-Line Panitumumab Rechallenge in Patients with Metastatic Wild-Type KRAS Colorectal Cancer Who Obtained Clinical Benefit from First-Line Panitumumab-Based Chemotherapy: JACCRO CC-09Akihito Tsuji, Masato Nakamura, Takanori Watanabe, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 7, 2023
Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 studyYasuhiro Kodera, Kazuhiro Yoshida, Mitsugu Kochi, et al.
Future Oncology (London, England)|May 30, 2019
DELIVER (JACCRO GC-08) trial: discover novel host-related immune-biomarkers for nivolumab in advanced gastric cancerYu Sunakawa, Eisuke Inoue, Ryo Matoba, et al.
Clinical Journal of Gastroenterology|June 21, 2022
Anti programmed death-ligand 1 antibody-related cholangitis without bile duct dilation or stenosisTetsushi Azami, Yuichi Takano, Jun Noda, et al.
Future Oncology (London, England)|July 17, 2023
The BEETS (JACCRO CC-18) trial: an observational and translational study of BRAF-mutated metastatic colorectal cancerChiaki Inagaki, Ryo Matoba, Satoshi Yuki, et al.
Cancer Chemotherapy and Pharmacology|March 19, 2011
Phase II study of FOLFOX4 with "wait and go" strategy as first-line treatment for metastatic colorectal cancerMitsugu Kochi, Wataru Ichikawa, Eiji Meguro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 13, 2014
Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancerMitsuru Sasako, Masanori Terashima, Wataru Ichikawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2012
Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancerMasanori Terashima, Koji Kitada, Atsushi Ochiai, et al.
Oncology and Therapy|October 9, 2021
18F-FDG-PET/CT as an imaging biomarker for regorafenib efficacy in metastatic colorectal cancer (JACCRO CC-12)Masato Nakamura, Hironaga Satake, Tamotsu Sagawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 18, 2016
Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric CancerWataru Ichikawa, Masanori Terashima, Atsushi Ochiai, et al.
Pageof 8